Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04745689 |
Title | Study of AZD2811 + Durvalumab in ES-SCLC (TAZMAN) |
Acronym | TAZMAN |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | AstraZeneca |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | POL | ESP |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Research Site | Grand Rapids | Michigan | 49503 | United States | Details | |
Research Site | Cheongju-si | 28644 | Korea, Republic of | Details | ||
Research Site | Jinju-si | 52727 | Korea, Republic of | Details | ||
Research Site | Seoul | 03722 | Korea, Republic of | Details | ||
Research Site | Seoul | 06591 | Korea, Republic of | Details | ||
Research Site | Seoul | 138-736 | Korea, Republic of | Details | ||
Research Site | Seoul | 6351 | Korea, Republic of | Details | ||
Research Site | Bydgoszcz | 85-796 | Poland | Details | ||
Research Site | Olsztyn | 10-357 | Poland | Details | ||
Research Site | Poznan | 60-693 | Poland | Details | ||
Research Site | Sevilla | 41071 | Spain | Details | ||
Research Site | Valencia | 46015 | Spain | Details |